- Home
- XYF vs AQST Comparison
XYF vs AQST Comparison
Compare XYF & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XYF
- AQST
- Stock Information
- Founded
- XYF 2014
- AQST 2004
- Country
- XYF China
- AQST United States
- Employees
- XYF N/A
- AQST N/A
- Industry
- XYF Finance: Consumer Services
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- XYF Finance
- AQST Health Care
- Exchange
- XYF Nasdaq
- AQST Nasdaq
- Market Cap
- XYF 708.7M
- AQST 809.3M
- IPO Year
- XYF 2018
- AQST 2018
- Fundamental
- Price
- XYF $12.95
- AQST $6.91
- Analyst Decision
- XYF
- AQST Strong Buy
- Analyst Count
- XYF 0
- AQST 7
- Target Price
- XYF N/A
- AQST $10.71
- AVG Volume (30 Days)
- XYF 158.2K
- AQST 3.2M
- Earning Date
- XYF 11-26-2025
- AQST 10-31-2025
- Dividend Yield
- XYF 4.35%
- AQST N/A
- EPS Growth
- XYF 41.77
- AQST N/A
- EPS
- XYF 5.32
- AQST N/A
- Revenue
- XYF $1,047,188,328.00
- AQST $44,132,000.00
- Revenue This Year
- XYF N/A
- AQST N/A
- Revenue Next Year
- XYF N/A
- AQST $51.39
- P/E Ratio
- XYF $2.42
- AQST N/A
- Revenue Growth
- XYF 45.10
- AQST N/A
- 52 Week Low
- XYF $6.04
- AQST $2.12
- 52 Week High
- XYF $20.36
- AQST $7.55
- Technical
- Relative Strength Index (RSI)
- XYF 41.73
- AQST 60.94
- Support Level
- XYF $12.30
- AQST $6.63
- Resistance Level
- XYF $13.11
- AQST $7.18
- Average True Range (ATR)
- XYF 0.60
- AQST 0.40
- MACD
- XYF -0.05
- AQST -0.05
- Stochastic Oscillator
- XYF 27.66
- AQST 60.67
About XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.